Of late, the potential of magic mushrooms as a tool to address various mental health issues, particularly depression, has sparked curiosity. A prevailing practice involves consuming a standard dose of approximately 25 mg of the active component, available for purchase from a mushroom dispensary. This dosage holds promise in providing relief and could potentially complement conventional depression treatments.
A study led by a group of scholars indicates that psilocybin, the active ingredient in magic mushrooms, has demonstrated promising results in the treatment of depression.
Key Observations:
- Psilocybin could alleviate symptoms of depression in as little as eight days.
- Side effects of Psilocybin are generally mild to moderate and are usually well-tolerated.
- A 25mg dose of psilocybin can trigger changes in perception, mood swings, elevated creativity, and a feeling of unity.

One Dose May Suffice
A recent research employed an exacting methodology, using a randomized, multi-blinded pattern to contrast a single dose of psilocybin with an active placebo (niacin). The exploration evaluated the onset, benefits duration, and safety of psilocybin over a span of six weeks.
Study Participants
The study included individuals aged 21 to 65 who met the Major Depressive Disorder (MDD) specifications as per the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) and were undergoing a depressive episode of at least 60 days at the time of the study.
Procedure
Participants received either a single 25-mg oral dose of psilocybin or a 100-mg dose of niacin. Niacin served as an active placebo, inducing an immediate physiological response (flushing) to maintain the blind aspect of the study.
Both the psilocybin and niacin placebo were administered following a standard “set and setting” protocol. The preparatory sessions, overseen by two facilitators, lasted between 6 and The application session, conducted in a relaxed atmosphere, typically lasted between 7 and 10 hours. Four hours after administration, participants were prompted to contemplate their experiences.
dosage.Insights Gained from the Study
Significant signs of depression reduction were observed just eight days post-psilocybin administration. This promising effect remained stable throughout the six-week follow-up duration, showing higher response and remission rates according to the Montgomery-Asberg Depression Rating Scale (MADRS), compared to other psilocybin studies and Treatment-Resistant Depression.
In comparison to niacin, psilocybin displayed improved psychosocial functioning. The administration of psilocybin demonstrated potential benefits in various areas, such as reducing overall disease severity, decreasing anxiety levels, self-reported depressive symptoms, and enhancing overall life quality.
The majority of the participants tolerated the compound well, experiencing minor to moderate side effects primarily following the initial dosage. However, the psilocybin treatment exhibited more frequent and severe side effects than niacin, which is consistent with our current understanding of its impact.
The researchers noted that psychedelics like psilocybin may produce side effects that standard rating scales might not always identify, or they could reveal previously undetected psychiatric conditions, even while effectively treating specific disorders.
What Does a 25-mg Dose Indicate?
A standard psychedelic dose typically falls between 15 to 25 milligrams of psilocybin (1.5 to 2.5 grams of dried mushrooms), which is the average dosage for individuals seeking the full psychedelic impact of magic mushrooms.
This dose can result in altered perception, mood shifts, enhanced creativity, and a feeling of unity with the environment. Although mild visual effects might occur, intense hallucinations are rare. The experience is akin to entering a vivid dreamworld where reality blends seamlessly with a captivating mix of visual and auditory sensations.
The euphoric feelings commonly manifest as dancing, gentle motion, or simply yielding to the psychedelic rhythm. The experience typically lasts between 4 to 8 hours. At this level, visual distortions may become more pronounced, with patterns appearing to move and change, and the environment seeming to pulsate with energy.
While this dose can be managed, it necessitates a regulated environment and a positive mindset. It offers a journey filled with amazement and discovery, inspiring you to explore consciousness. with a measure of excited caution.
- Enhancements in color perception that are more pronounced.
- Visual distortions, such as the appearance of objects shifting or “breathing”.
- The occurrence of synesthesia, where one sensory perception triggers another, like “seeing sounds” or “hearing colors”.
- The attainment of a deeper comprehension of music.
- Episodes of hearty laughter.
- Alterations in touch sensations.
- Engaging in introspective thinking.
- Feeling intense euphoria.
- Perceiving time differently.
- Experiencing an elevated heart rate and blood pressure.
Products Offered by Magic Mushroom Shops
Magic mushroom stores stock a variety of products infused with psilocybin. These stores offer a wide selection including dried mushrooms, edibles, capsules, drinks, and more. Dried mushrooms are particularly favored.
Health Canada recognizes over 200 varieties of magic mushrooms, with Psilocybe cubensis being a commonly sold type. This strain comes in several sub-varieties, providing a plentiful range for customers, similar to the choices available at cannabis dispensaries.
Other Shroom Products Include:
Edibles | Gummies, chocolates, and other food items are infused with psilocybin. The dosage is straightforward as the manufacturers specify the quantity per serving. |
Capsules | These are flavorless and can be seamlessly integrated into your wellness routine. They contain only minor quantities to subtly enhance your daily regimen. |
Beverages | These are akin to edibles, but in a liquid form. They come in a variety of options like chocolate, coffee, or tea. |
Establishing Your Dosage at Magic Mushroom Dispensaries
Even though magic mushrooms are not a standard treatment for depression, Canada has taken a progressive step. They have permitted the testing and medical usage of psilocybin, a Schedule I substance under the Controlled Drugs and Substances Act, for select patients suffering from severe major depressive disorder. This measure could potentially benefit tens of thousands exploring alternative treatment options for anxiety and depression through clinical trials.
Commonly Asked Questions
Can psilocybin be purchased from a medicinal mushroom dispensary?
A medicinal mushroom dispensary usually offers products like Reishi, Turkey Tail, and Lion’s Mane. For those interested in the mushroom realm, an online magic mushroom dispensary could be the perfect starting point. These dispensaries offer a range of mushroom products, such as dried mushrooms and other psychedelic substances.
Is a 25 mg dose effective for treating depression?
Research into the most effective psilocybin dosages for depression treatment is ongoing. Some studies have investigated lower doses, while others have examined higher ones. One approach might be to start with a microdose and gradually increase the dosage over time.
Can shrooms be purchased in Toronto?
Online mushroom retailers offer the convenience of shopping from anywhere in Canada. Regardless of your location, these online platforms ensure delivery directly to your doorstep.
What is the most economical product in an online mushroom shop?
Customers commonly prefer dried mushrooms due to the wide range of available quantities. The price may fluctuate depending on whether you require a small quantity like 1 gram or prefer to purchase in bulk. Although edibles and other products are fairly priced, they might not be as cost-effective as dried mushrooms.
Can a single dose of shrooms help alleviate depression?
Some studies indicate that a single use could potentially alleviate symptoms of depression. However, it’s important to remember that study subjects also engaged in talk therapy in conjunction with the treatment. This combination of psychedelic therapy and therapeutic sessions appears to yield the best results.
About the Author
Charles L. Raison et al., Jeremy D. Coplan, MD, Dorothy P. Reddy, MD, Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, and Roland R Griffiths, and Vince Polito are the authors of this article.
Richard J. Stevenson, Rebecca Smausz, Joanna Neill, and John Gigg are also contributors.
Affiliated Organizations:
- The Usona Institute, based in Fitchburg, Wisconsin
- SUNY Downstate Medical Center situated in Brooklyn, New York
- Neurogenesis Clinics in Brooklyn, New York
- The Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Department of Cognitive Science, Macquarie University in Sydney, Australia
- Department of Psychology, Macquarie University, Sydney, Australia
- The Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
- Medical Psychedelics Working Group associated with Drug Science, UK